- Home
- TOPP vs CALC Comparison
TOPP vs CALC Comparison
Compare TOPP & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- CALC
- Stock Information
- Founded
- TOPP 2014
- CALC 2011
- Country
- TOPP United States
- CALC United States
- Employees
- TOPP N/A
- CALC N/A
- Industry
- TOPP
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- CALC Health Care
- Exchange
- TOPP NYSE
- CALC Nasdaq
- Market Cap
- TOPP 22.4M
- CALC 25.2M
- IPO Year
- TOPP 2025
- CALC N/A
- Fundamental
- Price
- TOPP $1.22
- CALC $1.55
- Analyst Decision
- TOPP
- CALC Strong Buy
- Analyst Count
- TOPP 0
- CALC 3
- Target Price
- TOPP N/A
- CALC $16.33
- AVG Volume (30 Days)
- TOPP 91.6K
- CALC 60.4K
- Earning Date
- TOPP 01-01-0001
- CALC 05-12-2025
- Dividend Yield
- TOPP N/A
- CALC N/A
- EPS Growth
- TOPP N/A
- CALC N/A
- EPS
- TOPP 0.01
- CALC N/A
- Revenue
- TOPP $16,039,513.00
- CALC N/A
- Revenue This Year
- TOPP N/A
- CALC N/A
- Revenue Next Year
- TOPP N/A
- CALC N/A
- P/E Ratio
- TOPP $104.65
- CALC N/A
- Revenue Growth
- TOPP N/A
- CALC N/A
- 52 Week Low
- TOPP $1.05
- CALC $1.45
- 52 Week High
- TOPP $4.50
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- CALC 32.53
- Support Level
- TOPP N/A
- CALC $1.45
- Resistance Level
- TOPP N/A
- CALC $1.67
- Average True Range (ATR)
- TOPP 0.00
- CALC 0.15
- MACD
- TOPP 0.00
- CALC -0.01
- Stochastic Oscillator
- TOPP 0.00
- CALC 15.38
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.